Dajiang J. Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dajiang J. Liu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Charles Kooperberg
1] Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2] Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington, USA
2 shared publications- Gonçalo R. Abecasis
Regeneron Genetics Center, Tarrytown, USA
2 shared publications Kristian Hveem
1] HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Norway. [2] Department of Medicine, Levanger Hospital, Nord-Trøndelag Health Trust, Levanger, Norway
2 shared publicationsMajid Nikpay
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
2 shared publicationsMarju Orho-Melander
1] Department of Cardiovascular Medicine, University of Oxford, Oxford, UK. [2] Department of Clinical Sciences, Lund University, Malmö, Sweden
2 shared publicationsMartin Farrall
1] Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK. [2] Department of Cardiovascular Medicine, University of Oxford, Oxford, UK
2 shared publications
Latest Publications
- Open Access
- 15 December 2013
- Published by Springer Nature in Nature Genetics
- Vol. 46 (2) , 200-204
Meta-analysis of gene-level tests for rare variant association
Gonçalo Abecasis, Dajiang Liu and colleagues report a meta-analysis framework to identify rare variant associations based on gene-level tests and the use of shared summary statistics provided by individual studies. They demonstrate their approach on a meta-analysis of blood lipid levels including 18,699 individuals, drawn from across 7 studies and genotyped with exome arrays. The majority of reported complex disease associations for common genetic variants have been identified through meta-analysis, a powerful approach that enables the use of large sample sizes while protecting against common artifacts due to population structure and repeated small-sample analyses sharing individual-level data. As the focus of genetic association studies shifts to rare variants, genes and other functional units are becoming the focus of analysis. Here we propose and evaluate new approaches for performing meta-analysis of rare variant association tests, including burden tests, weighted burden tests, variable-threshold tests and tests that allow variants with opposite effects to be grouped together. We show that our approach retains useful features from single-variant meta-analysis approaches and demonstrate its use in a study of blood lipid levels in ∼18,500 individuals genotyped with exome arrays.
- 15 December 2013
- Published by Springer Nature in Nature Genetics
- Vol. 46 (2) , 200-204
Open AccessMeta-analysis of gene-level tests for rare variant association
Gonçalo Abecasis, Dajiang Liu and colleagues report a meta-analysis framework to identify rare variant associations based on gene-level tests and the use of shared summary statistics provided by individual studies. They demonstrate their approach on a meta-analysis of blood lipid levels including 18,699 individuals, drawn from across 7 studies and genotyped with exome arrays. The majority of reported complex disease associations for common genetic variants have been identified through meta-analysis, a powerful approach that enables the use of large sample sizes while protecting against common artifacts due to population structure and repeated small-sample analyses sharing individual-level data. As the focus of genetic association studies shifts to rare variants, genes and other functional units are becoming the focus of analysis. Here we propose and evaluate new approaches for performing meta-analysis of rare variant association tests, including burden tests, weighted burden tests, variable-threshold tests and tests that allow variants with opposite effects to be grouped together. We show that our approach retains useful features from single-variant meta-analysis approaches and demonstrate its use in a study of blood lipid levels in ∼18,500 individuals genotyped with exome arrays.
- Open Access
Meta-Analysis of Gene Level Association Tests
The vast majority of connections between complex disease and common genetic variants were identified through meta-analysis, a powerful approach that enables large samples sizes while protecting against common artifacts due to population structure, repeated small sample analyses, and/or limitations with sharing individual level data. As the focus of genetic association studies shifts to rare variants, genes and other functional units are becoming the unit of analysis. Here, we propose and evaluate new approaches for meta-analysis of rare variant association. We show that our approach retains useful features of single variant meta-analytic approaches and demonstrate its utility in a study of blood lipid levels in ~18,500 individuals genotyped with exome arrays.
Open AccessMeta-Analysis of Gene Level Association Tests
The vast majority of connections between complex disease and common genetic variants were identified through meta-analysis, a powerful approach that enables large samples sizes while protecting against common artifacts due to population structure, repeated small sample analyses, and/or limitations with sharing individual level data. As the focus of genetic association studies shifts to rare variants, genes and other functional units are becoming the unit of analysis. Here, we propose and evaluate new approaches for meta-analysis of rare variant association. We show that our approach retains useful features of single variant meta-analytic approaches and demonstrate its utility in a study of blood lipid levels in ~18,500 individuals genotyped with exome arrays.
- Open Access
- 15 November 2012
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 8 (11) , e1003075
A Unified Method for Detecting Secondary Trait Associations with Rare Variants: Application to Sequence Data
Next-generation sequencing has made possible the detection of rare variant (RV) associations with quantitative traits (QT). Due to high sequencing cost, many studies can only sequence a modest number of selected samples with extreme QT. Therefore association testing in individual studies can be underpowered. Besides the primary trait, many clinically important secondary traits are often measured. It is highly beneficial if multiple studies can be jointly analyzed for detecting associations with commonly measured traits. However, analyzing secondary traits in selected samples can be biased if sample ascertainment is not properly modeled. Some methods exist for analyzing secondary traits in selected samples, where some burden tests can be implemented. However p-values can only be evaluated analytically via asymptotic approximations, which may not be accurate. Additionally, potentially more powerful sequence kernel association tests, variable selection-based methods, and burden tests that require permutations cannot be incorporated. To overcome these limitations, we developed a unified method for analyzing secondary trait associations with RVs (STAR) in selected samples, incorporating all RV tests. Statistical significance can be evaluated either through permutations or analytically. STAR makes it possible to apply more powerful RV tests to analyze secondary trait associations. It also enables jointly analyzing multiple cohorts ascertained under different study designs, which greatly boosts power. The performance of STAR and commonly used RV association tests were comprehensively evaluated using simulation studies. STAR was also implemented to analyze a dataset from the SardiNIA project where samples with extreme low-density lipoprotein levels were sequenced. A significant association between LDLR and systolic blood pressure was identified, which is supported by pharmacogenetic studies. In summary, for sequencing studies, STAR is an important tool for detecting secondary-trait RV associations. Next-generation sequencing has greatly expanded our ability to identify missing heritability due to rare variants. In order to increase the power to detect associations, one desirable study design is to combine samples from multiple cohorts for mapping commonly measured traits. However, many current studies sequence selected samples (e.g. samples with extreme QT), which can bias the analysis of secondary traits, unless the sampling ascertainment mechanisms are properly adjusted. We developed a unified method for detecting secondary trait associations with rare variants (STAR) in selected and random samples, which can flexibly incorporate all rare variant association tests and allow joint analysis of multiple cohorts ascertained under different study designs. We demonstrate via simulations that STAR greatly boosts the power for detecting secondary trait associations. As an application of STAR, a dataset from the SardiNIA project was analyzed, where DNA samples from well-phenotyped individuals with extreme low-density lipoprotein levels were sequenced. LDLR was identified to be significantly associated with systolic blood pressure, which is supported by a previous pharmacogenetics study. In conclusion, STAR is an important tool for sequence-based association studies.
- 15 November 2012
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 8 (11) , e1003075
Open AccessA Unified Method for Detecting Secondary Trait Associations with Rare Variants: Application to Sequence Data
Next-generation sequencing has made possible the detection of rare variant (RV) associations with quantitative traits (QT). Due to high sequencing cost, many studies can only sequence a modest number of selected samples with extreme QT. Therefore association testing in individual studies can be underpowered. Besides the primary trait, many clinically important secondary traits are often measured. It is highly beneficial if multiple studies can be jointly analyzed for detecting associations with commonly measured traits. However, analyzing secondary traits in selected samples can be biased if sample ascertainment is not properly modeled. Some methods exist for analyzing secondary traits in selected samples, where some burden tests can be implemented. However p-values can only be evaluated analytically via asymptotic approximations, which may not be accurate. Additionally, potentially more powerful sequence kernel association tests, variable selection-based methods, and burden tests that require permutations cannot be incorporated. To overcome these limitations, we developed a unified method for analyzing secondary trait associations with RVs (STAR) in selected samples, incorporating all RV tests. Statistical significance can be evaluated either through permutations or analytically. STAR makes it possible to apply more powerful RV tests to analyze secondary trait associations. It also enables jointly analyzing multiple cohorts ascertained under different study designs, which greatly boosts power. The performance of STAR and commonly used RV association tests were comprehensively evaluated using simulation studies. STAR was also implemented to analyze a dataset from the SardiNIA project where samples with extreme low-density lipoprotein levels were sequenced. A significant association between LDLR and systolic blood pressure was identified, which is supported by pharmacogenetic studies. In summary, for sequencing studies, STAR is an important tool for detecting secondary-trait RV associations. Next-generation sequencing has greatly expanded our ability to identify missing heritability due to rare variants. In order to increase the power to detect associations, one desirable study design is to combine samples from multiple cohorts for mapping commonly measured traits. However, many current studies sequence selected samples (e.g. samples with extreme QT), which can bias the analysis of secondary traits, unless the sampling ascertainment mechanisms are properly adjusted. We developed a unified method for detecting secondary trait associations with rare variants (STAR) in selected and random samples, which can flexibly incorporate all rare variant association tests and allow joint analysis of multiple cohorts ascertained under different study designs. We demonstrate via simulations that STAR greatly boosts the power for detecting secondary trait associations. As an application of STAR, a dataset from the SardiNIA project was analyzed, where DNA samples from well-phenotyped individuals with extreme low-density lipoprotein levels were sequenced. LDLR was identified to be significantly associated with systolic blood pressure, which is supported by a previous pharmacogenetics study. In conclusion, STAR is an important tool for sequence-based association studies.
- Open Access
- 3 May 2012
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 28 (13) , 1745-1751
SEQCHIP: a powerful method to integrate sequence and genotype data for the detection of rare variant associations
Motivation: Next-generation sequencing greatly increases the capacity to detect rare-variant complex-trait associations. However, it is still expensive to sequence a large number of samples and therefore often small datasets are used. Given cost constraints, a potentially more powerful two-step strategy is to sequence a subset of the sample to discover variants, and genotype the identified variants in the remaining sample. If only cases are sequenced, directly combining sequence and genotype data will lead to inflated type-I errors in rare-variant association analysis. Although several methods have been developed to correct for the bias, they are either underpowered or theoretically invalid. We proposed a new method SEQCHIP to integrate genotype and sequence data, which can be used with most existing rare-variant tests. Results: It is demonstrated using both simulated and real datasets that the SEQCHIP method has controlled type-I errors, and is substantially more powerful than all other currently available methods. Availability: SEQCHIP is implemented in an R-Package and is available at http://linkage.rockefeller.edu/suzanne/seqchip/Seqchip.htm Contacts:dajiang@umich.edu or sleal@bcm.edu Supplementary information: Supplementary data are available at Bioinformatics online.
- 3 May 2012
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 28 (13) , 1745-1751
Open AccessSEQCHIP: a powerful method to integrate sequence and genotype data for the detection of rare variant associations
Motivation: Next-generation sequencing greatly increases the capacity to detect rare-variant complex-trait associations. However, it is still expensive to sequence a large number of samples and therefore often small datasets are used. Given cost constraints, a potentially more powerful two-step strategy is to sequence a subset of the sample to discover variants, and genotype the identified variants in the remaining sample. If only cases are sequenced, directly combining sequence and genotype data will lead to inflated type-I errors in rare-variant association analysis. Although several methods have been developed to correct for the bias, they are either underpowered or theoretically invalid. We proposed a new method SEQCHIP to integrate genotype and sequence data, which can be used with most existing rare-variant tests. Results: It is demonstrated using both simulated and real datasets that the SEQCHIP method has controlled type-I errors, and is substantially more powerful than all other currently available methods. Availability: SEQCHIP is implemented in an R-Package and is available at http://linkage.rockefeller.edu/suzanne/seqchip/Seqchip.htm Contacts:dajiang@umich.edu or sleal@bcm.edu Supplementary information: Supplementary data are available at Bioinformatics online.